APA (7th ed.) Citation

L, T., M, Z., J, G., W, C., X, Z., J, H., & L, S. (2025). Efficacy and Safety of Remimazolam versus Dexmedetomidine and Midazolam in Awake Endotracheal Intubation for Difficult Airway Patients: A Randomized Controlled Study. Drug design, development and therapy, 19, 10633. https://doi.org/10.2147/DDDT.S564228

Chicago Style (17th ed.) Citation

L, Tang, Zhang M, Guo J, Chen W, Zhao X, Huang J, and Sheng L. "Efficacy and Safety of Remimazolam Versus Dexmedetomidine and Midazolam in Awake Endotracheal Intubation for Difficult Airway Patients: A Randomized Controlled Study." Drug Design, Development and Therapy 19 (2025): 10633. https://doi.org/10.2147/DDDT.S564228.

MLA (9th ed.) Citation

L, Tang, et al. "Efficacy and Safety of Remimazolam Versus Dexmedetomidine and Midazolam in Awake Endotracheal Intubation for Difficult Airway Patients: A Randomized Controlled Study." Drug Design, Development and Therapy, vol. 19, 2025, p. 10633, https://doi.org/10.2147/DDDT.S564228.